《港股開市》恆指高開38點 京東漲逾3%
美股道指升37點或0.1%,納指跌0.5%。港股早市高開,恆指高開38點或0.2%,報17,120點;國指高開8點或0.1%,報5,940點;恆生科技指數高開12點或0.3%,報3,668點。
友邦(01299.HK)去年新業務價值40.34億美元,按實質匯率計升30%符預期,股價高開0.2%報65元。匯控(00005.HK)低開0.2%報59.2元,港交所(00388.HK)高開1.4%報254.2元。
科技股方面,京東(09618.HK)高開3.3%報109.8元,國務院總理李強北京調研到訪百度(09888.HK)亦莊辦公區,百度高開1.3%。網易(09999.HK)高開1.1%報173.8元。此外,阿里(09988.HK)及美團(03690.HK)高開0.4%及0.2%,騰訊(00700.HK)及快手(01024.HK)低開0.4%,嗶哩嗶哩(09626.HK)低開2.9%。
車股方面,小鵬(09868.HK)核心管理層變動,2位聯合創始人退出,股價低開2.2%。小米(01810.HK)汽車SU7頂配版據報價格超過30萬人幣,股價低開0.1%。蔚來(09866.HK)低開2.5%。比亞迪(01211.HK)平開報209.4元。
醫藥股走高,石藥(01093.HK)、藥明生物(02269.HK)及翰森製藥(03692.HK)高開逾3%,中生製藥(01177.HK)高開2.5%,藥明康德(02359.HK)高開4.7%。
新秀麗(01910.HK)去年純利升33%,擬每股派息10.34美仙,新秀麗高開0.3%報29.4元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.